Dachaigh › Leukemia biphenotypic geur › Washington › Seattle
Sgrùdaidhean clionaigeach Leukemia biphenotypic geur ann an Seattle, WA
Tha 15 sgrùdaidhean airson Leukemia biphenotypic geur a’ lorg phàirtichean aig làraichean ann agus timcheall air Seattle (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
A’ fastadhÌre 1
- Fred Hutchinson Cancer Center, Seattle
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
A’ fastadhÌre 2
- Seattle Children's Hospital, Seattle
CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
A’ fastadhÌre 1
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms
A’ fastadh
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
A’ fastadhÌre 3
- Seattle Children's Hospital, Seattle
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
A’ fastadhÌre 1/2
- Seattle Children's Hospital, Seattle
Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
A’ fastadhÌre 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer
A’ fastadhÌre 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
A’ fastadhÌre 1/2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
A’ fastadhÌre 1/2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
A’ fastadhÌre 2Fàilte do shaor-thoilich fhallain
- Fred Hutch/University of Washington Cancer Consortium, Seattle
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
A’ fastadhÌre 1
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse
A’ fastadhÌre 1/2Fàilte do shaor-thoilich fhallain
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms
A’ fastadhÌre 1/2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
A’ fastadhÌre 1
- Seattle Children's Hospital, Seattle
Sgrùdaidhean Leukemia biphenotypic geur ann am bailtean eile
- Houston, TX11 sgrùdadh
- New York City, NY10 sgrùdaidhean
- Atlanta, GA9 sgrùdaidhean
- Durham, NC8 sgrùdaidhean
- Memphis, TN7 sgrùdaidhean
- Chicago, IL7 sgrùdaidhean
- Charlotte, NC6 sgrùdaidhean
- Baldwin Park, CA6 sgrùdaidhean
- Aurora, CO6 sgrùdaidhean
- Dallas, TX6 sgrùdaidhean
- Philadelphia, PA6 sgrùdaidhean
- Portland, OR6 sgrùdaidhean
Sgrùdaidhean eile ann an Seattle
- Aillse Sgamhain Neo-chealla-beag53 sgrùdaidhean
- Aillse (gach seòrsa)49 sgrùdaidhean
- Aillse Prostata42 sgrùdaidhean
- Leukemia myeloid geur41 sgrùdaidhean
- Aillse a' bhroilleach39 sgrùdaidhean
- Ailse metastatach39 sgrùdaidhean
- Aillse colorectal34 sgrùdaidhean
- Ailseachadh nan Sgamhan33 sgrùdaidhean
- Cancer Ovarian30 sgrùdaidhean
- Myeloma iomaill22 sgrùdaidhean
- Aillse sa bhlaire21 sgrùdaidhean
- Siondròman Myelodysplastic21 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.